Report of Foreign Issuer (6-k)
May 27 2020 - 7:40AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
Form 6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of May 2020
Commission
File Number 001-38370
CollPlant
Biotechnologies Ltd.
(Exact
name of registrant as specified in its charter)
4
Oppenheimer St, Weizmann Science Park
Rehovot
7670104, Israel
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7): ☐
The text under the headings “First Quarter
2020 Financial Results on US GAAP basis (“GAAP”)”, “First Quarter 2020 Financial Results on Non-US GAAP
Basis (“non-GAAP”)”, the accompanying consolidated financial statements and “Forward Looking Statements”
of the press release attached to this Form 6-K are hereby incorporated by reference into the registrant’s Registration Statements
on Form S-8 (File No. 333-229163) and Form F-3 (File No. 333-229486 and 333-228054), to be a part thereof from the date on which
this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
Attached
hereto as Exhibit 99.1 and incorporated by reference herein is a press release issued by the Registrant entitled “CollPlant
Biotechnologies Reports First Quarter (Q1) 2020 Financial Results.”
Exhibit
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
COLLPLANT
BIOTECHNOLOGIES LTD.
|
|
|
|
Date:
May 27, 2020
|
By:
|
/s/
Eran Rotem
|
|
|
Name:
Eran Rotem
|
|
|
Title:
Deputy CEO and Chief Financial Officer
|
2
CollPlant Biotechnologies (NASDAQ:CLGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
CollPlant Biotechnologies (NASDAQ:CLGN)
Historical Stock Chart
From Sep 2023 to Sep 2024